Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3073 studies found for:    "Hepatitis A"
Show Display Options
Rank Status Study
1 Completed Immunogenicity Study of an Inactivated Hepatitis A Vaccine in Infants and Young Children
Condition: Hepatitis A
Intervention: Biological: hepatitis A vaccine
2 Completed The Effects of Honey, as a Dietary Supplement in Children With Hepatitis A
Condition: Hepatitis A
Interventions: Dietary Supplement: honey;   Dietary Supplement: molasses
3 Completed Hepatitis A Vaccination in the Elderly
Condition: Hepatitis A
Intervention:
4 Completed Regulatory Post-Marketing Surveillance Study for Hepatitis A Vaccine (AVAXIM 160U)
Condition: Hepatitis A
Intervention:
5 Completed A Study to Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A
Condition: Hepatitis A
Intervention: Biological: Hepatitis A vaccine
6 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine, Injected According to 0, 6-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
7 Completed
Has Results
Long-Term Immune Persistence of GlaxoSmithKline Biologicals' Inactivated Hepatitis A Vaccine Injected According to a 0, 12-month Schedule
Condition: Hepatitis A
Intervention: Biological: Havrix™
8 Completed Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and Adolescents
Conditions: Hepatitis A;   Hepatitis A Virus
Intervention: Biological: Avaxim 80U Pediatric: Inactivated Hepatitis A Virus
9 Completed The Fifth-year Follow-up Study for the Phase IV Clinical Trial of Hepatitis A Vaccine in Healthy Children
Condition: Hepatitis A
Interventions: Biological: Inactivated HAV vaccine;   Biological: Attenuated alive HAV vaccine
10 Completed
Has Results
A Study to Evaluate the Safety and Immunogenicity of the Hepatitis A Virus Vaccine HAVpur in Healthy Young Children
Condition: Hepatitis A
Interventions: Biological: HAVpur Junior;   Biological: Havrix 720 Junior
11 Withdrawn Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®
Condition: Hepatitis A
Intervention: Procedure: Blood sampling
12 Completed The Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Condition: Hepatitis A
Interventions: Biological: Attenuated HAV Vaccine, H2 Strain;   Biological: Attenuated HAV Vaccine, L-A-1 Strain;   Biological: Inactivated HAV Vaccine, Lu8 Strain;   Biological: Inactivated HAV Vaccine, TZ84 Strain
13 Completed Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines
Condition: Hepatitis A
Interventions: Biological: Attenuated Hepatitis A Vaccine, H2 Strain;   Biological: Inactivated Hepatitis A Vaccine, Lu8 Strain;   Biological: Group A Meningococcal Polysaccharide vaccine
14 Completed
Has Results
Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™ (Hepatitis A vaccine);   Biological: Comparator: ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine);   Biological: Comparator: Prevnar™ (Pneumococcal 7-Valent Conjugate vaccine)
15 Completed
Has Results
Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)
Condition: Hepatitis A Virus
Interventions: Biological: Comparator: VAQTA™;   Biological: Comparator: Infanrix™;   Biological: Comparator: PedvaxHIB™
16 Completed Safety, Immunogenicity, and Immune Persistence Study of an Inactivated Hepatitis A Vaccine
Condition: Hepatitis A
Interventions: Biological: Healive® Lot 1;   Biological: Healive® Lot 2;   Biological: Healive® Lot 3;   Biological: Havrix
17 Completed Long Term Follow-up of a Study to Assess the Safety and Immunogenicity of a Hepatitis A Vaccine Administered With and in the Absence of DTPaHibIPV, OPV and MMR Vaccines
Condition: Hepatitis A
Interventions: Biological: Epaxal;   Biological: Havrix 720
18 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Intervention: Biological: Twinrix™ adult
19 Completed Hepatitis A Vaccine in Patients With Immunomodulating Drugs
Condition: Response to Hepatitis A Vaccine
Intervention: Biological: hepatitis A vaccine ( HAVRIX or EPAXAL)
20 Completed
Has Results
Long-Term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,6 Month Schedule
Conditions: Hepatitis B;   Hepatitis A
Interventions: Biological: TWINRIX™ ADULT;   Biological: Engerix TM

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.